Volume 24, Issue 1 (Scientific Journal of Hamadan University of Medical Sciences-Spring 2017)                   Avicenna J Clin Med 2017, 24(1): 32-40 | Back to browse issues page

XML Persian Abstract Print

1- Hamadan University of Medical Sciences
2- Hamadan University of Medical Sciences , mahaliz@yahoo.com
Abstract:   (5029 Views)

Introduction: Chronic renal disease compromises of several renal involvements and several causative risk factors such as debates mellitus, hypertension, and old age. Ocular involvement seems to be related to chronic renal failure and hemodialysis as indicated by different studies. The aim of this study was the evaluation of prevalence of ocular manifestation in hemodialysis patients of Hamadan Besat hospital.

Methods: This research was a cross sectional descriptive study, in which ocular signs in 74 hemodialysis patients, who referred to Besat hospital of Hamadan, Iran, during year 2015, were evaluated. Collected information related to patients included age, gender, dialysis duration, and background risk factors of chronic renal failure. All patients had been exanimated by an ophthalmologist.

Results: Fifty percent of patients in the study were male and 50% were female. Average age of patients was 58.8 years and median duration of dialysis was 40.16 months. Mean visual acuity was 4.58 (of 10). Most common ocular manifestations were: macula abnormality (59.5%), cataract (56.7%), eye pain (56.7%), eye redness (52.7%), dry eyes (50%), and eyelid edema (43.2%), respectively.

Conclusions: Hypertension and diabetes mellitus are the most common causes of chronic renal failure. The most common ocular manifestations were macular abnormality followed by cataract. According to high prevalence of these complications in hemodialysis patients, regular monitoring of patients for early detection and thus effective treatment seems to be necessary to improve their quality of life.

Full-Text [PDF 369 kb]   (4539 Downloads)    
Type of Study: Original | Subject: Other Clinical Specialties

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.